Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EMA Confirms Recommendation Of Synchron Suspensions
But Finds Alternative Data To Support Marketing Authorizations For Eight Medicines
Sep 19 2022
•
By
Dave Wallace
The EMA has confirmed its recommendation to suspend dozens of marketing authorizations
More from Regulation
More from Policy & Regulation